![]() |
|
|
Vol. 289, Issue 3, 1545-1552, June 1999
Department of Pharmacology, The George Washington University
Medical Center, Washington, DC (D.C.P.); Department of Pharmacology,
Georgetown University School of Medicine, Washington, DC (M.I.D-G.,
K.J.K.); and Department of Psychiatry, Case Western Reserve University
School of Medicine, Cleveland, Ohio (C.A.S.)
Chronic administration of nicotine increases the density of neuronal
cholinergic nicotinic receptors in cells and in rodent brain, and
similar increases have been reported in brains from human smokers. To
further examine this phenomenon, we measured nicotinic receptor binding
sites in brain regions from matched populations of smokers and
nonsmokers. We first measured binding of
[3H](±)epibatidine ([3H]EB) and
[3H]cytisine in homogenate preparations from samples of
prefrontal and temporal cerebral cortex. Binding of each radioligand
was significantly higher (250-300%) in both cortical regions from brains of smokers. Frozen sections from each of the cerebral cortical regions and the hippocampus were used for autoradiographic analysis of
[3H]EB binding. In cerebral cortex, binding was most
dense in layer VI in the prefrontal cortex and layers IV and VI in the
temporal cortex. Densitometric analysis of [3H]EB binding
sites revealed marked increases of 300 to 400% of control in all
cortical regions examined from smokers' brains. Binding in the
hippocampal formation was heterogeneously distributed, with dense areas
of binding sites seen in the parasubiculum, subiculum, and molecular
layer of the dentate gyrus, and the lacunosum-moleculare layer of the
CA1/2. Binding of [3H]EB was significantly higher
in all six regions of the hippocampus examined from brains of smokers
compared with nonsmokers. These increases ranged from 160% of control
in parasubiculum to 290% in the molecular layer of the dentate gyrus.
The increase in nicotinic receptors in the cerebral cortex and
hippocampus of smokers may modify the central nervous system effects of
nicotine and contribute to an altered response of smokers to nicotine.
This article has been cited by other articles:
![]() |
K. P. Cosgrove, J. Batis, F. Bois, P. K. Maciejewski, I. Esterlis, T. Kloczynski, S. Stiklus, S. Krishnan-Sarin, S. O'Malley, E. Perry, et al. {beta}2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking Arch Gen Psychiatry, June 1, 2009; 66(6): 666 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Schroeder A 51-Year-Old Woman With Bipolar Disorder Who Wants to Quit Smoking JAMA, February 4, 2009; 301(5): 522 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function Physiol Rev, January 1, 2009; 89(1): 73 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Markou Neurobiology of nicotine dependence Phil Trans R Soc B, October 12, 2008; 363(1507): 3159 - 3168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Arredondo, A. I. Chernyavsky, D. L. Jolkovsky, K. E. Pinkerton, and S. A. Grando Receptor-mediated tobacco toxicity: acceleration of sequential expression of {alpha}5 and {alpha}7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke FASEB J, May 1, 2008; 22(5): 1356 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Walsh, A. P. Govind, R. Mastro, J. C. Hoda, D. Bertrand, Y. Vallejo, and W. N. Green Up-regulation of Nicotinic Receptors by Nicotine Varies with Receptor Subtype J. Biol. Chem., March 7, 2008; 283(10): 6022 - 6032. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mamede, K. Ishizu, M. Ueda, T. Mukai, Y. Iida, H. Kawashima, H. Fukuyama, K. Togashi, and H. Saji Temporal Change in Human Nicotinic Acetylcholine Receptor After Smoking Cessation: 5IA SPECT Study J. Nucl. Med., November 1, 2007; 48(11): 1829 - 1835. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Perry, D. Mao, A. B. Gold, J. M. McIntosh, J. C. Pezzullo, and K. J. Kellar Chronic Nicotine Differentially Regulates {alpha}6- and beta3-Containing Nicotinic Cholinergic Receptors in Rat Brain J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 306 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Hope, D. Nagarkar, S. Leonard, and R. A. Wise Long-Term Upregulation of Protein Kinase A and Adenylate Cyclase Levels in Human Smokers J. Neurosci., February 21, 2007; 27(8): 1964 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bordia, N. Parameswaran, H. Fan, J. W. Langston, J. M. McIntosh, and M. Quik Partial Recovery of Striatal Nicotinic Receptors in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Monkeys with Chronic Oral Nicotine J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Staley, S. Krishnan-Sarin, K. P. Cosgrove, E. Krantzler, E. Frohlich, E. Perry, J. A. Dubin, K. Estok, E. Brenner, R. M. Baldwin, et al. Human Tobacco Smokers in Early Abstinence Have Higher Levels of beta2* Nicotinic Acetylcholine Receptors than Nonsmokers. J. Neurosci., August 23, 2006; 26(34): 8707 - 8714. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human {alpha}4{beta}2 Acetylcholine Receptors Mol. Pharmacol., December 1, 2005; 68(6): 1839 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Ficklin, S. Zhao, and G. Feng Ubiquilin-1 Regulates Nicotine-induced Up-regulation of Neuronal Nicotinic Acetylcholine Receptors J. Biol. Chem., October 7, 2005; 280(40): 34088 - 34095. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Schroeder What to Do With a Patient Who Smokes JAMA, July 27, 2005; 294(4): 482 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. F. Vallejo, B. Buisson, D. Bertrand, and W. N. Green Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism J. Neurosci., June 8, 2005; 25(23): 5563 - 5572. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hukkanen, P. Jacob III, and N. L. Benowitz Metabolism and Disposition Kinetics of Nicotine Pharmacol. Rev., March 1, 2005; 57(1): 79 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Huang, X. Wang, C. Evans, A. Gold, E. Bouairi, and D. Mendelowitz Prenatal Nicotine Exposure Alters the Types of Nicotinic Receptors That Facilitate Excitatory Inputs to Cardiac Vagal Neurons J Neurophysiol, October 1, 2004; 92(4): 2548 - 2554. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bibevski and M. E. Dunlap Prevention of diminished parasympathetic control of the heart in experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1780 - H1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mamede, K. Ishizu, M. Ueda, T. Mukai, Y. Iida, H. Fukuyama, T. Saga, and H. Saji Quantification of Human Nicotinic Acetylcholine Receptors with 123I-5IA SPECT J. Nucl. Med., September 1, 2004; 45(9): 1458 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xiao and K. J. Kellar The Comparative Pharmacology and Up-Regulation of Rat Neuronal Nicotinic Receptor Subtype Binding Sites Stably Expressed in Transfected Mammalian Cells J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 98 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Iida, M. Ogawa, M. Ueda, A. Tominaga, H. Kawashima, Y. Magata, S. Nishiyama, H. Tsukada, T. Mukai, and H. Saji Evaluation of 5-11C-Methyl-A-85380 as an Imaging Agent for PET Investigations of Brain Nicotinic Acetylcholine Receptors J. Nucl. Med., May 1, 2004; 45(5): 878 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sallette, S. Bohler, P. Benoit, M. Soudant, S. Pons, N. Le Novere, J.-P. Changeux, and P. J. Corringer An Extracellular Protein Microdomain Controls Up-regulation of Neuronal Nicotinic Acetylcholine Receptors by Nicotine J. Biol. Chem., April 30, 2004; 279(18): 18767 - 18775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Parker, Y. Fu, K. McAllen, J. Luo, J. M. McIntosh, J. M. Lindstrom, and B. M. Sharp Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the {alpha}6 Subunit Mol. Pharmacol., March 1, 2004; 65(3): 611 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nashmi, M. E. Dickinson, S. McKinney, M. Jareb, C. Labarca, S. E. Fraser, and H. A. Lester Assembly of {alpha}4{beta}2 Nicotinic Acetylcholine Receptors Assessed with Functional Fluorescently Labeled Subunits: Effects of Localization, Trafficking, and Nicotine-Induced Upregulation in Clonal Mammalian Cells and in Cultured Midbrain Neurons J. Neurosci., December 17, 2003; 23(37): 11554 - 11567. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Nguyen, B. A. Rasmussen, and D. C. Perry Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1090 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Avila, M. I. Davila-Garcia, V. S. Ascarrunz, Y. Xiao, and K. J. Kellar Differential Regulation of Nicotinic Acetylcholine Receptors in PC12 Cells by Nicotine and Nerve Growth Factor Mol. Pharmacol., October 1, 2003; 64(4): 974 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Micu, S. Miksys, E. M. Sellers, D. R. Koop, and R. F. Tyndale Rat Hepatic CYP2E1 Is Induced by Very Low Nicotine Doses: An Investigation of Induction, Time Course, Dose Response, and Mechanism J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 941 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cohen, O. E. Bergis, F. Galli, A. W. Lochead, S. Jegham, B. Biton, J. Leonardon, P. Avenet, F. Sgard, F. Besnard, et al. SSR591813, a Novel Selective and Partial {alpha}4{beta}2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 407 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Henningfield, E T Moolchan, and M Zeller Regulatory strategies to reduce tobacco addiction in youth Tob. Control, June 1, 2003; 12(90001): i14 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Howard, A. L. Micu, E. M. Sellers, and R. F. Tyndale Low Doses of Nicotine and Ethanol Induce CYP2E1 and Chlorzoxazone Metabolism in Rat Liver J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 542 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Girod and L. W. Role Long-Lasting Enhancement of Glutamatergic Synaptic Transmission by Acetylcholine Contrasts with Response Adaptation after Exposure to Low-Level Nicotine J. Neurosci., July 15, 2001; 21(14): 5182 - 5190. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Buisson and D. Bertrand Chronic Exposure to Nicotine Upregulates the Human {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Function J. Neurosci., March 15, 2001; 21(6): 1819 - 1829. [Abstract] [Full Text] [PDF] |
||||